Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:        
Net loss $ (4,397) $ (3,275) $ (14,901) $ (13,141)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 32 54 115 161
Amortization of right-of-use assets     182 168
Unrealized loss on investment 4 5 4 10
Share-based compensation expense     325 702
Changes in operating assets and liabilities:        
Trade and other receivables     (50) 47
Prepaid expense and other assets     (14) 609
Trade and other payables     580 512
Accrued employee benefits     30 28
Lease liabilities     (188) (140)
Net cash used in operating activities     (13,917) (11,044)
Cash flows from financing activities:        
Proceeds from issuance of common stock, pre-funded warrants, and common warrants     17,884  
Shares and pre-funded warrant issuance costs     (1,869)  
Net cash provided by financing activities     16,015  
Effects of exchange rate changes on cash, cash equivalents, and restricted cash     391 (95)
Net increase (decrease) in cash, cash equivalents, and restricted cash     2,489 (11,139)
Cash, cash equivalents, and restricted cash, beginning of period     4,076 19,769
Cash, cash equivalents, and restricted cash, end of period $ 6,565 $ 8,630 6,565 8,630
Supplemental disclosure of cash flow information:        
Re-measurement of operating lease right-of-use assets and liabilities     $ 0 $ 794